Martin Auster – Raymond James

Raymond James

A Raymond James analyst with 10 tracked ratings across 8 distinct tickers holds a 4.5-star track record and has achieved a perfect 100% success rate on the captured sample.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

3 days ago

2026-06-01 00:00:00+00

Track record

Aggregated

No track record data

Bullish: 15
Hold: 1
Bearish: 0

Aggregated

100% success rate

Bullish: 0
Hold: 0
Bearish: 0

Aggregated

Not available

Bullish: 8
Hold: 2
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
EWTX	2026-06-01	buy	$66.00	Aggregated
EQ	2026-05-28	buy	$7.00	Aggregated
BBIO	2026-05-26	hold	-	Aggregated
EWTX	2026-05-04	buy	$46.00	Aggregated
EQ	2026-04-14	buy	$6.00	Aggregated
SYRE	2026-04-14	buy	$80.00	Aggregated
EQ	2026-04-10	buy	$6.00	Aggregated
SYRE	2026-04-10	buy	$80.00	Aggregated
SRRK	2026-03-30	buy	$60.00	Aggregated
MAZE	2026-03-25	buy	$56.00	Aggregated
EVMN	2026-01-26	buy	$40.00	Aggregated
BBIO	2026-01-13	buy	$85.00	Aggregated
IRON	2026-01-13	buy	$117.00	Aggregated
WVE	2026-01-13	buy	$26.00	Aggregated
EVMN	2026-01-08	buy	$40.00	Aggregated
SEPN	2025-12-19	buy	$38.00	Aggregated
PHAT	2025-12-11	buy	$28.00	Aggregated
BBIOBRIDGEBIO PHARMA INC	2025-10-30	unknown	$71.00	Aggregated
RNA	2025-10-27	hold	-	Aggregated
ASND	2025-10-17	buy	$271.00	Aggregated
IRON	2025-10-17	buy	$108.00	Aggregated
DYN	2025-08-25	buy	$35.00	Aggregated
DYNDYNE THERAPEUTICS INC	2025-08-25	unknown	$35.00	Aggregated
DYN	2025-07-29	buy	$31.00	Aggregated

Tickers covered(16)

Ticker	Ratings	Last rating	Sources
EWTX	2	2026-06-01	Aggregated
EQ	3	2026-05-28	Aggregated
BBIO	3	2026-05-26	Aggregated
SYRE	2	2026-04-14	Aggregated
SRRK	1	2026-03-30	Aggregated
MAZE	1	2026-03-25	Aggregated
EVMN	2	2026-01-26	Aggregated
IRON	2	2026-01-13	Aggregated
WVE	1	2026-01-13	Aggregated
SEPN	2	2025-12-19	Aggregated
PHAT	1	2025-12-11	Aggregated
BBIOBRIDGEBIO PHARMA INC	2	2025-10-30	Aggregated
RNA	1	2025-10-27	Aggregated
ASND	2	2025-10-17	Aggregated
DYN	3	2025-08-25	Aggregated
DYNDYNE THERAPEUTICS INC	2	2025-08-25	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.